Clinical Laboratory Evaluation of Chronic Autonomic Failure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03648905

Title field or adapter rule

{'original_value': 'Clinical Laboratory Evaluation of Chronic Autonomic Failure', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:33.604872+00:00

Published At

2026-10-26T00:00:00+00:00

Record Updated At

2026-10-26

Source Retrieved At

2026-10-31T22:18:37.902788+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Parkinson\u0027s Disease", "Multiple System Atrophy", "Autonomic Failure"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-26", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT03648905"

protocolSection.identificationModule.officialTitle

"Clinical Laboratory Evaluation of Chronic Autonomic Failure"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Parkinson's Disease (protocolSection.conditionsModule.conditions)
• Multiple System Atrophy (protocolSection.conditionsModule.conditions)
• Autonomic Failure (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Control patients (PD No OH)', 'Control patients (iatrogenic CAF)', 'Healthy Volunteers', 'Patients with neurodegenerative chronic autonomic failure (CAF)'], 'description': 'a perfusion imaging agent', 'name': '13N-Ammonia', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Control patients (PD No OH)', 'Control patients (iatrogenic CAF)', 'Healthy Volunteers', 'Patients with neurodegenerative chronic autonomic failure (CAF)'], 'description': 'is a positron-emitting analog of the catechol amino acid, levodopa', 'name': '18F-DOPA', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Control patients (PD No OH)', 'Control patients (iatrogenic CAF)', 'Healthy Volunteers', 'Patients with neurodegenerative chronic autonomic failure (CAF)'], 'description': '11C-MRB may be injected IV for visualizingsites of neuronal uptake of norepinephrine in the brain or periphery by PET scanning. Setup includes placement of an arm IV catheter. 11C-MRB is a Radioactive Research Drug.', 'name': '11C-Methylreboxetine (11C-MRB)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Control patients (PD No OH)', 'Control patients (iatrogenic CAF)', 'Healthy Volunteers', 'Patients with neurodegenerative chronic autonomic failure (CAF)'], 'description': 'is a positron-emitting analog of the catecholamine, dopamine', 'name': '18F-Dopamine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• 13N-Ammonia (protocolSection.armsInterventionsModule.interventions[].name)
• 18F-DOPA (protocolSection.armsInterventionsModule.interventions[].name)
• 11C-Methylreboxetine (11C-MRB) (protocolSection.armsInterventionsModule.interventions[].name)
• 18F-Dopamine (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.